Kedrion S.p.A.

Kedrion S.p.A.

Kedrion S.p.A.

Overview
Date Founded

2001

Headquarters

Localita Ai Conti,Castelvecchio Pascoli,Barga, Lucca 55051

Type of Company

Private

Industries

Pharmaceuticals
Holding Companies
Biotechnology

Company Description

Kedrion SpA develops and markets biopharmaceutical products. It operates as a biopharmaceutical company which specializes in the development, production, and distribution of plasma-derived products. The firm collects and fractionates blood plasma to produce and distribute plasma-derived therapeutic products for use in treating serious diseases, disorders and conditions such as hemophilia and immune system deficiencies. It serves medical and scientific, and institutional patient communities worldwide. The company was founded in 2001 and is headquartered in Barga, Italy.

Website
Executives & Employees

Chairman & Chief Executive Officer

Chief Financial Officer

Chief Operating Officer

Chief Commercial Officer

Chief Regulatory & Compliance Officer

General Manager

Vice Chairman

Director-Quality Assurance

Director-Plasma Business Unit

Director-Global Supply Chain

Board of Directors

Chairman & Chief Executive Officer at Kedrion S.p.A.

Vice Chairman at Kedrion S.p.A.

Chief Operating Officer at Global Engineering & Construction Group

Former Partner at Investitori Associati Sgr SpA

Director at Kedrion S.p.A.

Former Partner at Investitori Associati Sgr SpA

Director at Kedrion S.p.A.

Paths to Kedrion S.p.A.
Potential Connections via
Relationship Science
You
Kedrion S.p.A.
Recent Transactions
Details Hidden

Groupe Marcucci SA purchases Kedrion S.p.A.

Details Hidden

Kedrion S.p.A. purchases Ortho Clinical Diagnostics, Inc. /RhoGam Business from Johnson & Johnson

Details Hidden

Kedrion S.p.A. purchases Grifols SA /US Fractionation FVII & Plasma Collection Bus from Grifols SA

Transaction Advisors
Legal Advisor

Advised onKedrion S.p.A. purchases Grifols SA /US Fractionation FVII & Plasma Collection Bus from Grifols SA

Investments
Details Hidden

Hardis SpA manufactures pharmaceutical products. The company specializes in the production of immunoglobins and inactive blood plasma for transfusion usage. The company was founded in 2000 and headquartered in Sant'Antimo, Italy.

Investors
Details Hidden
Details Hidden

CDP Equity is an active, long-term manager which invests in strategic companies with net annual turnover of at least EUR 240 million and an average of at least 200 employees which operate in the defense, security, infrastructure and public services, transportation, communication, energy, insurance and financial intermediation, research and high technology sectors, aiming to achieve market returns through a combination of dividends and capital gains.The firm invests in companies seeking to expand, improve operational efficiency and strengthen their competitive position in both domestic and international markets. They typically acquire minority interests in companies of major national interest with a sound financial position, adequate profitability and growth prospects. They are also open to working with co-investors on investment deals and play an active role in the governance of their investee companies.CDP Equity establishes appropriate mechanisms to ensure the liquidity and monetization of their investments in order to preserve, leverage and make the capital provided by shareholders available for the future. A typical investee company shareholder agreement provides for representation on the Board of Directors, rights regarding key operational matters and extraordinary corporate initiatives and agreement on the business plan and various initiatives.Their investment process involves transparent decision making. Each investment must be approved by the firm's Investment Committee and Board of Directors.

Details Hidden

IA invests in the Italian mid-market segment across industrial, commercial and service sectors. In partnership with the portfolio firm's management, IA's investment objective is to create value. They look for transaction values of at least €100 million. They typically acquire 100% or a controlling stake of the portfolio firm, either independently or in partnership with other investors. IA also takes minority stakes in special situations where the exit strategy is clearly defined and viable.IA considers three types of private equity investments: leveraged acquisitions with investments in market- or niche-leading firms having robust cash-flows and stable performances; turnaround situations with financing in underperforming firms which have identified re-launch strategies and restructuring policies; development capital for firms with clearly defined growth plans through specific industrial projects.Within their targeted industry sectors, the firm has specifically invested in diverse areas such as publishing, automotive components, textile machinery, radiology equipment, biodegradable materials, online trading, packaging, pharmaceutical logistical services, food, sportswear, rubber and plastic, and distribution.IA is an active investment manager. In addition to financial support, they provide management expertise through strategy definition and access to their network of industry experts.

Suppliers
Grifols SA Pharmaceuticals | Barcelona, CT

Grifols SA is a vertically integrated global producer of plasma derivatives. Its activities include sourcing raw material, manufacturing various plasma derivative products and selling and distributing final products to healthcare providers. The company operates through the following segments: Bioscience, Hospital, Diagnostic and Raw Materials. The Bioscience segment includes all activities related with products deriving from human plasma for therapeutic use. The Hospital segment comprises of all non-biological pharmaceutical products and medical supplies manufactured by group companies earmarked for hospital pharmacy. The Diagnostic segment includes the marketing of diagnostic testing equipment, reagents, and other equipment. The Raw Materials segment includes the sale of intermediate biological products and the rendering of manufacturing services to third party companies. Grifols was founded by José Antonio Grifols Roig on November 18, 1940 and is headquartered in Barcelona, Spain.

Spectris Plc Appliances & Electronics | Egham, SU

Spectris develops and markets productivity-enhancing instrumentation and controls. The company had sales of £1,106.2 million in 2011 and employs around 7,600 people worldwide. Spectris is listed on the London Stock Exchange (symbol – SXS) and is a member of techMARK, the London Stock Exchange’s index for technology companies, and the FTSE4Good index of socially-responsible companies.

FullSIX SpA Internet Software & Services | Milan, MI

FullSix SpA engages in the provision of innovation and digital communication services. It operates through the following business segments: Digital, System, and Technology. The Digital segment offers personalized media and research solutions such as advertising budget planning and implementation of social media marketing strategies. The System segment includes activities related to mobile telephony and infrastructure services. The Technology segment provides technical implementation and platform integration. The company was founded on January 11, 1988 and is headquartered in Milan, Italy.